Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2024)
Aurora Cannabis (ACB) reported Non Operating Investment Income of -$1.6 million for Q2 2024, down 742.08% quarter-over-quarter from -$194489.6 in Q4 2022.
Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2024) Analysis & Trends
Aurora Cannabis (ACB) has 7 years of Non Operating Investment Income data on file, last reported at -$1.6 million in Q2 2024.
- Non Operating Investment Income for Q2 2024 came in at -$1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was -$3.2 million (changed N/A YoY), and the FY2023 annual result was $1.4 million, up 275.43% from the prior year.
- Non Operating Investment Income retreated to -$1.6 million in Q2 2024 per ACB's latest filing, from -$194489.6 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $17.3 million in Q4 2020 and troughed at -$21.1 million in Q3 2021.
- A 4-year average of -$2.3 million and a median of -$704429.0 in 2021 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2020 and 2021: Non Operating Investment Income jumped 299.03% in 2020, then tumbled 482.33% in 2021.
- A 4-year view of Non Operating Investment Income shows it stood at $17.3 million in 2020, then plunged by 103.69% to -$638635.5 in 2021, then jumped by 69.55% to -$194489.6 in 2022, then plunged by 742.08% to -$1.6 million in 2024.
- Business Quant data shows ACB's Non Operating Investment Income at -$1.6 million in Q2 2024, -$194489.6 in Q4 2022, and -$577359.9 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -1.64 Mn |
| Jun 30, 2024 | -1.64 Mn |
| Dec 31, 2022 | -194,489.58 |
| Dec 31, 2022 | -194,489.58 |
| Sep 30, 2022 | -577,359.92 |
| Sep 30, 2022 | -577,359.92 |
| Jun 30, 2022 | -770,222.52 |
| Jun 30, 2022 | -770,222.52 |
| Mar 31, 2022 | 502,106.36 |
| Mar 31, 2022 | 502,106.36 |
| Dec 31, 2021 | -638,635.55 |
| Dec 31, 2021 | -638,635.55 |
| Sep 30, 2021 | -21.13 Mn |
| Sep 30, 2021 | -21.13 Mn |
| Jun 30, 2021 | -12.64 Mn |
| Jun 30, 2021 | -12.64 Mn |
| Mar 31, 2021 | -2.57 Mn |
| Mar 31, 2021 | -2.57 Mn |
| Dec 31, 2020 | 17.31 Mn |
| Dec 31, 2020 | 17.31 Mn |